We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Mustang

News List

Mustang Bio, CSL Behring Enter License Agreement for Stable Producer Cell Line contractpharma
August 28, 2019
Cytegrity™ is a stable producer cell line developed by St. Jude Children’s Research Hospital for the treatment of X-linked severe combined immunodeficiency.
Mustang Bio’s AML Treatment Receives Orphan Drug Designation contractpharma
July 31, 2019
MB-102 (CD123 CAR T) evaluated to treat AML and BPDCN.
Mustang Bio and Fred Hutchinson Cancer Research Center enters into an agreement biospectrumasia
September 19, 2017
As part of the transaction, Mustang entered into an investigator-initiated clinical trial agreement to provide partial funding for a Phase 1/2 clinical trial at Fred Hutch